In the management of fluid overload in a client with heart failure, monitoring for hyperkalemia is necessary because of the potassium-sparing effect of which of these drugs?

Explanation

• Lisinopril is in a group of drugs called angiotensin-converting enzyme (ACE) inhibitors. Lisinopril is used to treat high blood pressure (hypertension), heart failure, and to improve survival after a myocardial infarction. When it is used, the client should be monitored for hyperkalemia.

• Eprosartan is used alone or in combination with other medications to treat high blood pressure. Eprosartan is in a class of medications called angiotensin II receptor antagonists. When it is used, client should be monitored for hyperkalemia.

• Spironolactone causes increased amounts of sodium and water to be excreted, while potassium is retained. It acts both as a diuretic and as an antihypertensive drug. When it is used, client should be monitored for hyperkalemia.

Incorrect options:

• Hydrochlorothiazide is used to treat high blood pressure and fluid retention caused by various conditions, including heart disease. Its adverse effect is hypokalemia.

• Furosemide is used to reduce the swelling and fluid retention caused by various medical problems, including heart or liver disease. Its adverse effect is hypokalemia.

• Bumetanide, a loop diuretic like furosemide, is used to reduce the swelling and fluid retention caused by various medical problems, including heart or liver disease. Its adverse effect is hypokalemia.

Visit our website for other NCLEX topics now!